Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Giovita, Piccillo"'
Autor:
Fabio Salvatore Macaluso, Maria Cappello, Federica Crispino, Mauro Grova, Antonino Carlo Privitera, Giovita Piccillo, Antonio Magnano, Concetta Ferracane, Nunzio Belluardo, Emiliano Giangreco, Walter Fries, Anna Viola, Roberto Di Mitri, Filippo Mocciaro, Salvatore Camilleri, Serena Garufi, Sara Renna, Angelo Casà, Marcello Maida, Ambrogio Orlando
Publikováno v:
Digestive and Liver Disease. 54:629-634
The role of Vedolizumab (VDZ) as therapeutic option for the postoperative recurrence of Crohn's disease (CD) following ileocolonic resection is unknown.To assess the effectiveness of VDZ in this setting.All consecutive CD patients with a baseline col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79f3a52c44f7f88dfc726a820024a56
https://doi.org/10.1016/j.dld.2021.11.021
https://doi.org/10.1016/j.dld.2021.11.021
Autor:
A. Trovatello, Giulia Rizzuto, Marco Ventimiglia, E. Giangreco, Andrea Centritto, R. Orlando, Fabio Salvatore Macaluso, Giovita Piccillo, Maria Cappello, E. Giuffrida, C. Bertolami, Walter Fries, R. Vassallo, S. Camilleri, A. Magnano, Sara Renna, Ambrogio Orlando, Anna Viola, Antonino Carlo Privitera, N. Belluardo, Elisa Vinci, S. Garufi
Publikováno v:
Inflammatory Bowel Diseases. 27:182-189
Background No data on the recently introduced infliximab (IFX) biosimilar SB2 in inflammatory bowel disease (IBD) are available. Methods The Sicilian Prospective Observational Study of Patients With IBD Treated With Infliximab Biosimilar SB2 is a mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109a32cabf881d905239a1e1a3212c55
https://doi.org/10.1093/ibd/izaa036
https://doi.org/10.1093/ibd/izaa036
Autor:
Fabio Salvatore Macaluso, A. Magnano, Sara Renna, Marco Ventimiglia, Ambrogio Orlando, Elisa Vinci, C. Ferracane, Giulia Rizzuto, B. Scrivo, Giovita Piccillo, Francesco Graziano, Claudio Romano, A. Casà, S. Garufi, Walter Fries, C. Bertolami, Maria Cappello, Anna Viola, Giuseppe Costantino, Giulia Teresi, Antonino Carlo Privitera, N. Belluardo, E. Giangreco, Michele Citrano, A. Busacca
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(11)
BACKGROUND AND AIM There are few clinical data on Adalimumab (ADA) biosimilars in inflammatory bowel disease. We aimed to perform a multicenter, observational, prospective study on safety and effectiveness of ADA biosimilar ABP 501 in patients with i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f0ad369d94144ec00ae9b0bd49ea090
https://pubmed.ncbi.nlm.nih.gov/34152636
https://pubmed.ncbi.nlm.nih.gov/34152636
Autor:
Elisa Vinci, Fabio Salvatore Macaluso, Maria Cappello, Giuseppe Costantino, C. Ferracane, Marco Ventimiglia, Francesco Graziano, Walter Fries, S. Garufi, A. Magnano, Giovita Piccillo, Anna Viola, Antonino Carlo Privitera, Sara Renna, N. Belluardo, Claudio Romano, Ambrogio Orlando, B. Scrivo, E. Giangreco, Michele Citrano, A. Busacca, Rizzuto Giulia, A. Casà, C. Bertolami
Publikováno v:
Inflammatory Bowel Diseases. 27:S59-S59
Background and Aims There are few clinical data on Adalimumab (ADA) biosimilars in inflammatory bowel disease. Methods SPOSAB ABP 501 is a multicenter, observational, prospective study performed among the cohort of the Sicilian Network for Inflammato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98275dc8fff9b189a7fad971d510a881
https://doi.org/10.1093/ibd/izaa347.141
https://doi.org/10.1093/ibd/izaa347.141
Autor:
Giovita, Piccillo, Aurelio, Pantò, Leonardo, Salmeri, Azzarelli, SALVATORE A., Mondati, Enrico, Riccardo, Polosa, Giovanni, Gasbarrini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::f6db0171d9d38133ee84a40edee00410
http://hdl.handle.net/20.500.11769/80520
http://hdl.handle.net/20.500.11769/80520
